Neotherix projects and other activities were covered in a recent Super North Life Sciences supplement for The Times, published on 23 February 2016. The Bionow awards for 2015 included the RegeniTherix™ Wound Theranostic System as the winner of the Project of the Year Award (for which Neotherix is a member of a consortium led by NPL and including SensaPharm, Complement Genomics and Leeds Teaching Hospitals). The potential of this product to improve the treatment of chronic wounds was noted and was that of Neotherix' lead product EktoTherix™ - currently undergoing clinical investigation - for the repair of acute (surgical) wounds. Neotherix CEO Mike Raxworthy's contribution to the Super North Forum on the strength of the life sciences sector in the North of England was also recognised.
Please see the attached Super North supplement (copyright ©2016 Super North).